Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis

Acta Oto-Laryngologica, Supplement

Volumn , Issue 525, 1996, Pages 73-78

  Hashiba, Motoyuki ^a   Baba, Shunkichi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Clinical efficacy; Erythromycin derivative; Long term therapy; Macrolide

Indexed keywords

CLARITHROMYCIN; ANTIINFECTIVE AGENT; ERYTHROMYCIN;

ADULT; AGED; ARTICLE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; ADOLESCENT; CHRONIC DISEASE; DOSE RESPONSE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; SINUSITIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; SINUSITIS; TREATMENT OUTCOME;

EID: 0029658771     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kikuchi S, Suzaki H, Aoki A, Ito O, Nomura Y. Clinical effect of long-term low-dose erythromycin therapy for chronic sinusitis (in Japanese with English abstract). Pract. Otol (Kyoto) 1991; 84: 41-7.
2. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983; 83: 63-9.
3. Kudoh S, Kimura H, Uetake K, et al. Clinical effect of low-dose long-term macrolides chemotherapy on diffuse panbronchiolitis. Jap J Thorac Dis 1984; (suppl) 22: 254. (in Japanese).
4. Kudoh S, Uetake K, Hagiwara K, et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis (in Japanese with English abstract). Jap J Thorac Dis 1987; 25: 632-42.
5. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991; 58: 145-9.
6. Mikasa K, Sawaki M, Kita E, et al. Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases - the fourth report (in Japanese with English abstract). Kansenshogaku Zasshi 1992; 66: 1097-104.
7. Takeda H, Miura H, Kawahira M, Kobayashi H, Otomo S, Nakaike S. Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis (in Japanese with English abstract). Kansenshogaku Zasshi 1989; 63: 71-8.
8. Hashiba M, Miyamoto N, Kimura T, Kobayashi T, Baba S. Efficacy of the erythromycin derivative, clarithromycin in the treatment of chronic sinusitis. Am J Rhinol 1994; Suppl 8: 348-9.
9. Takagita S, Kitamura H, Oyagi S, et al. Clinical effect of low-dose erythromycin chemotherapy on chronic sinusitis (in Japanese with English abstract). Pract Otol (Kyoto) 1991; 84: 489-98.
10. Kikuchi S, Yamasoba T, Suzaki H, Aoki A, Hara M, Nomura Y. Long-term low-dose erythromycin therapy for chronic sinusitis (in Japanese with English abstract). Pract Otol (Kyoto) 1992; 85: 1245-52.
11. Sawaki M, Mikami R, Mikasa K, Kunimatsu M, Ito S, Narita N. The long term chemotherapy with erythromycin in chronic lower respiratory tract infections - first report: comparison with amoxicillin (in Japanese with English abstract). Kansenshogaku Zasshi 1986; 60: 37-44.
12. Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99: 670-3.
13. Ochiai T, Nakajima K, Nagata M, et al. Effect of a new immunosuppressive agent, FK506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc 1987; 19 (1 Pt 2): 1284-6.
14. Goswami SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 1990; 141: 72-8.
15. Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 1992; 5: 234-8.
16. Ichikawa Y, Ninomiya H, Koga H, et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992; 146: 196-203.
17. Oda H, Kadota J, Kohno S, Hara K. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest 1994; 106: 1116-23.
18. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153-9.
19. Konno S, Adachi M, Asano K, Okamoto K, Takahashi T. Inhibition of human T-lymphocyte activation by macrolide antibiotic, roxithromycin. Life Sci 1992; 51: 1231-6.
20. Kita E, Sawaki M, Nishikawa F, et al. Enhanced interleukin production after long-term administration of erythromycin stearate. Pharmacology 1990; 41: 177-83.
21. Kita E, Sawaki M, Oku D et al. Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin. J Antimicrob Chemother 1991; 27: 273-84.
22. Ohgaki N. Bacterial biofilm in chronic airway infection. Kansenshogaku Zasshi 1994; 68: 138-51.